Paratus Sciences Funding: $100M Raised, Series A (2023)

Paratus Sciences funding overview

Paratus Sciences is based in New York, NY. Paratus Sciences has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Paratus Sciences runs through 2023; nothing later has been disclosed. Investors on record include Polaris Partners, ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.

Paratus Sciences at a glance

Total raised: $100M
Latest round: Series A
Latest round date: March 2023
Headquarters: New York, NY
Notable investors: Polaris Partners, ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Alexandria Venture Investments

Frequently asked about Paratus Sciences funding

How much has Paratus Sciences raised?: Paratus Sciences has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Paratus Sciences?: Polaris Partners, ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Alexandria Venture Investments are named among the investors backing Paratus Sciences.
What was the latest Paratus Sciences funding round?: The most recent disclosed round is a Series A, announced in March 2023.
Where is Paratus Sciences based?: Paratus Sciences is based in New York, NY.
When did Paratus Sciences last raise?: The last disclosed Paratus Sciences round closed in March 2023 at Series A.

Paratus Sciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.

Paratus Sciences Funding: $100M Raised, Series A (2023)

Paratus Sciences funding overview

Paratus Sciences at a glance

Frequently asked about Paratus Sciences funding

Companies related to Paratus Sciences (36)

Browse related funding lists (9)